John M. Maraganore
2010
In 2010, John M. Maraganore earned a total compensation of $1.3M as Chief Executive Officer at Alnylam Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $60,900 |
|---|---|
| Option Awards | $727,695 |
| Salary | $525,000 |
| Other | $15,084 |
| Total | $1,328,679 |
Maraganore received $727.7K in option awards, accounting for 55% of the total pay in 2010.
Maraganore also received $60.9K in non-equity incentive plan, $525K in salary and $15.1K in other compensation.
Rankings
In 2010, John M. Maraganore's compensation ranked 4,350th out of 10,439 executives tracked by ExecPay. In other words, Maraganore earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,350 out of 10,439 | 58th |
Division Manufacturing | 1,546 out of 3,837 | 60th |
Major group Chemicals And Allied Products | 308 out of 925 | 67th |
Industry group Drugs | 169 out of 684 | 75th |
Industry Pharmaceutical Preparations | 132 out of 480 | 73rd |
Source: SEC filing on May 2, 2011.
Maraganore's colleagues
We found five more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2010.
2010
Laurence Reid
Alnylam Pharmaceuticals
Senior Vice President and Chief Business Officer
2010
Kenneth Koblan
Alnylam Pharmaceuticals
Chief Scientific Officer
2010
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2010
Akshay Vaishnaw
Alnylam Pharmaceuticals
Senior Vice President, Clinical Research
2010
Patricia Allen
Alnylam Pharmaceuticals